Horn Kinney 4
4 · Olema Pharmaceuticals, Inc. · Filed Feb 3, 2022
Insider Transaction Report
Form 4
Horn Kinney
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-01+133,000→ 133,000 totalExercise: $7.02Exp: 2032-01-31→ Common Stock (133,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.